当前位置： SCI文献检索 > PHARMACOEPIDEMIOLOGY AND DRUG SAFETY期刊下所有文献 > Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD.

Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD.

Abstract：

BACKGROUND:Stimulants and atomoxetine should generally not be used or used only with caution in adults with pre-existing cardiovascular conditions. The extent to which pre-existing cardiovascular conditions influence initiation of these ADHD medications in adults is not known. METHODS:We performed a retrospective cohort study of privately insured adults with new ADHD treatment episodes. Pre-existing cardiovascular conditions were assessed by the presence of ICD-9-CM codes for congenital abnormalities, atherosclerosis, cardiac disease, and cerebrovascular disease in the 12 months before the index ADHD diagnosis. The primary outcome was new initiation of a stimulant or atomoxetine in the 3 months after the index date. Multivariate logistic regression was used to predict the likelihood of treatment initiation with stimulants or atomoxetine based on pre-existing cardiovascular conditions, patient demographic characteristics, clinical mental disorder comorbidities, other psychotropic drug use, and provider type. RESULTS:Of 8752 patients with a new ADHD treatment episode, 917 (10.5%) had evidence of >or=1 pre-existing cardiovascular condition. Stimulants were started by 40.8% of patients with and 53.0% of patients without pre-existing cardiovascular conditions (Adjusted Odds Ratio, AOR 0.71; 95%CI 0.61-0.82). Pre-existing cardiovascular conditions reduced the likelihood of initiating stimulant treatment in younger but not in older patients (p-value for age x cardiovascular condition interaction = 0.0002). Initiation of atomoxetine treatment was not affected by pre-existing cardiovascular conditions (AOR 1.19, 95%CI 0.94-1.50). CONCLUSIONS:Pre-existing cardiovascular conditions reduce the likelihood of stimulant therapy but not atomoxetine treatment in adult ADHD patients. However, many adult ADHD patients with pre-existing cardiovascular conditions initiate stimulant therapy.

journal_name

Pharmacoepidemiol Drug Saf

journal_title

Pharmacoepidemiology and drug safety

authors

Gerhard T,Winterstein AG,Olfson M,Huang C,Saidi A,Crystal S

doi

10.1002/pds.1931

subject

Has Abstract

pub_date

2010-05-01 00:00:00

pages

457-64

issue

5

eissn

1053-8569

issn

1099-1557

journal_volume

19

pub_type

杂志文章

相关文献

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY文献大全
  • Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: a cohort study.

    abstract：PURPOSE:Warfarin is commonly used among patients who receive influenza, pneumococcal, and tetanus and diphtheria toxoid vaccines, and persons on warfarin therapy may also receive Hepatitis A vaccine. There has been concern that vaccinations could potentially alter coagulation parameters in patients on warfarin therapy....

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1386

    authors： Jackson ML,Nelson JC,Chen RT,Davis RL,Jackson LA,Vaccine Safety Datalink investigators.

    更新日期：2007-07-01 00:00:00

  • Systematic review of cross-national drug utilization studies in Latin America: methods and comparability.

    abstract：PURPOSE:We systematically review the cross-national drug utilization studies performed in Latin America (LA) in order to analyze the methods applied and assess the validity of the data to ensure the comparability. METHODS:A systematic search in Medline, Embase, and BIREME was performed. Drug utilization studies includ...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章,评审

    doi：10.1002/pds.3896

    authors： Durán CE,Christiaens T,Acosta Á,Vander Stichele R

    更新日期：2016-01-01 00:00:00

  • Patient focused drug surveillance of elderly patients in nursing homes.

    abstract：PURPOSE:To examine whether patient focused drug surveillance was associated with a higher quality of drug treatment at nursing homes. METHODS:An intervention study in four nursing homes in Sweden and four other nursing homes served as controls. At the intervention nursing homes physicians focused on patients' health s...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1891

    authors： Olsson IN,Curman B,Engfeldt P

    更新日期：2010-02-01 00:00:00

  • Pattern of adverse drug reactions to anti-epileptic drugs: a cross-sectional one-year survey at a tertiary care hospital.

    abstract：PURPOSE:To investigate pattern and extent of adverse drug reactions (ADRs) associated with AEDs and to identify safer options for treatment of epilepsy. METHOD:Study was a retrospective, cross-sectional survey. Data from patients with epilepsy at the out-patient and in-patient of Neurology Department was collected in ...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1540

    authors： S RB,Narayan SS,Sharma GR,Rodrigues RJ,Kulkarni C

    更新日期：2008-08-01 00:00:00

  • The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy.

    abstract：PURPOSE:To evaluate whether the risk of coronary heart disease (CHD) differs among adult diabetic patients treated with thiazolidinediones (TZDs) and similar patients treated with combined oral metformin and sulfonylurea (M + S) therapy. METHODS:We conducted a retrospective cohort study involving 25 140 diabetic patie...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1356

    authors： Johannes CB,Koro CE,Quinn SG,Cutone JA,Seeger JD

    更新日期：2007-05-01 00:00:00

  • Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease.

    abstract：PURPOSE:Chronic kidney disease (CKD) is a prevalent and important outcome and covariate in pharmacoepidemiology. The Health Improvement Network (THIN) in the UK represents a unique resource for population-based studies of CKD. We compiled a valid list of Read codes to identify subjects with moderate to advanced CKD. M...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.2203

    authors： Denburg MR,Haynes K,Shults J,Lewis JD,Leonard MB

    更新日期：2011-11-01 00:00:00

  • Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users.

    abstract：PURPOSE:Fear of discontinuing concomitant anti-epileptic drugs (AEDs) may lead to potentially unnecessary and perhaps unsafe polypharmacy. The effect of withdrawing concomitant AEDs on epilepsy control was therefore studied in long-term users of levetiracetam. METHODS:The EULEV cohort followed patients initiating leve...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.3338

    authors： Droz-Perroteau C,Marchal C,Dureau-Pournin C,Lassalle R,Jové J,Robinson P,Lavernhe G,Vespignani H,Moore N,Fourrier-Réglat A,Eulev Study Group.

    更新日期：2012-11-01 00:00:00

  • Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014.

    abstract：PURPOSE:Long-term benzodiazepine (BZD) treatment continues to be a debated topic. Because individual BZDs have different clinical profiles, we assessed the nationwide trends of long-term BZD use at active substance level during years 2006 to 2014. METHODS:This study covered all reimbursed BZD purchases (n = 408 572-52...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.4551

    authors： Kurko T,Saastamoinen LK,Tuulio-Henriksson A,Taiminen T,Tiihonen J,Airaksinen M,Hietala J

    更新日期：2018-06-01 00:00:00

  • Confounding by indication: the case of calcium channel blockers.

    abstract：PURPOSE:To review conceptual issues regarding confounding by indication in the context of studies of calcium channel blockers (CCBs). METHODS:Review of literature, with special attention to two articles in the current issue. RESULTS:Conflicting arguments about the presence of uncontrollable confounding by indication ...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/(SICI)1099-1557(200001/02)9:1<37::AID-PDS4

    authors： Joffe MM

    更新日期：2000-01-01 00:00:00

  • Drug safety data mining with a tree-based scan statistic.

    abstract：PURPOSE:In post-marketing drug safety surveillance, data mining can potentially detect rare but serious adverse events. Assessing an entire collection of drug-event pairs is traditionally performed on a predefined level of granularity. It is unknown a priori whether a drug causes a very specific or a set of related adv...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.3423

    authors： Kulldorff M,Dashevsky I,Avery TR,Chan AK,Davis RL,Graham D,Platt R,Andrade SE,Boudreau D,Gunter MJ,Herrinton LJ,Pawloski PA,Raebel MA,Roblin D,Brown JS

    更新日期：2013-05-01 00:00:00

  • Hospital usage of antibacterial agents in relation to size and type of hospital and geographical situation.

    abstract：PURPOSE:The objective of this study was to evaluate the level of use and therapy profile of antibacterial agents in hospitals. Further to explore whether type, size or geographical situation influenced antibacterial agents used. METHODS:Antibacterial use during 1998-1999, in 13 hospitals, including emergency, referral...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1080

    authors： Blix HS,Hartug S

    更新日期：2005-09-01 00:00:00

  • Maternal use of antibiotics and the risk of orofacial clefts: a nationwide cohort study.

    abstract：PURPOSE:To study the association between antibiotic use in early pregnancy and the risk of isolated orofacial clefts. METHODS:We conducted a cohort study of 806,011 live births in Denmark from 1996 through September 2008. Individual-level information on prescribed antibiotics during pregnancy, orofacial cleft diagnosi...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.2179

    authors： Mølgaard-Nielsen D,Hviid A

    更新日期：2012-03-01 00:00:00

  • Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network.

    abstract：PURPOSE:The aims of this study are to examine the validity of diagnostic codes for psoriatic arthritis in The Health Improvement Network (THIN) and to examine the agreement between General Practitioner (GP) report and prescription records for disease modifying antirheumatic drugs (DMARDs). METHODS:Questionnaires were ...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.3677

    authors： Ogdie A,Alehashemi S,Love TJ,Jiang Y,Haynes K,Hennessy S,Choi H,Gelfand JM

    更新日期：2014-09-01 00:00:00

  • Phosphodiesterase type 5 inhibitor use among pregnant and reproductive-age women in the United States.

    abstract：PURPOSE:To assess the prevalence and potential indications of PDE5 inhibitor use among pregnant and reproductive-age women in the United States. METHODS:We identified women 15 to 50 years with a livebirth from January 2001 through March 2018 in Sentinel Database. We assessed the prevalence of PDE5 inhibitor use prior ...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.5112

    authors： Liu W,Menzin TJ,Woods CM,Haug NR,Li J,Mathew JA,Nguyen CP,Chai GP,Moeny DG,Shinde M

    更新日期：2021-02-01 00:00:00

  • Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram.

    abstract：PURPOSE:Three recent observational studies reported that the risk of fatal overdose is greater with venlafaxine than SSRI use. It is not clear whether patient factors could account for this finding. We evaluated whether risk factors for suicide are more prevalent among patients prescribed venlafaxine than patients pres...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1095

    authors： Mines D,Hill D,Yu H,Novelli L

    更新日期：2005-06-01 00:00:00

  • Tramadol dependence: a survey of spontaneously reported cases in Sweden.

    abstract：BACKGROUND:Tramadol is a weak opioid analgesic, which is generally considered to be safe. However, conflicting data exist on the dependence potential of tramadol. OBJECTIVE:The aim of this study was to investigate occurrence of tramadol dependence and associated risk factors using spontaneously reported adverse drug r...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1838

    authors： Tjäderborn M,Jönsson AK,Ahlner J,Hägg S

    更新日期：2009-12-01 00:00:00

  • Uses of proton pump inhibitors and serum potassium levels.

    abstract：PURPOSE:Proton pump inhibitor (PPI) may suppress adrenal cortical steroid synthesis and release, thereby leading to electrolyte disturbances. Both hyponatremia and hyperkalemia in the setting of PPI therapy have been documented in case reports. The objective of this study was to examine the association between serum po...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1795

    authors： Gau JT,Heh V,Acharya U,Yang YX,Kao TC

    更新日期：2009-09-01 00:00:00

  • Who are we missing? Underrepresentation of data sources used for pharmacoepidemiology research in the United States.

    abstract：PURPOSE:Research using healthcare databases often includes patients frequently excluded from clinical trials; yet it is not known whether commonly used data represents the overall population or specific sub-populations of interest. We aimed to examine population representativeness from data sources in recent research s...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.5087

    authors： Kaviani P,Landi SN,McKethan A,Brookhart MA,McGrath LJ

    更新日期：2020-11-01 00:00:00

  • Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients.

    abstract：PURPOSE:Ejection fraction (EF) is crucial information when studying the use and effectiveness of therapies in patients with heart failure (HF) and myocardial infarction (MI). We aimed to assess the validity of claims data-based definitions of systolic dysfunction (SD). METHODS:We identified 1072 patients with EF recor...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.2146

    authors： Li Q,Glynn RJ,Dreyer NA,Liu J,Mogun H,Setoguchi S

    更新日期：2011-07-01 00:00:00

  • Characteristics and trends of low-dose quetiapine use in two western state Medicaid programs.

    abstract：PURPOSE:Medicaid programs are concerned about inappropriate, potentially hazardous, and costly off-label use of second-generation antipsychotics (SGAs). Several states are exploring policies aimed at managing low-dose quetiapine, commonly prescribed for off-label conditions. This study aimed to characterize longitudina...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.3538

    authors： Hartung DM,Zerzan J,Yamashita T,Tong S,Morden NE,Libby AM

    更新日期：2014-01-01 00:00:00

  • Guidelines for good database selection and use in pharmacoepidemiology research.

    abstract：:The use of healthcare databases in research provides advantages such as increased speed, lower costs and limitation of some biases. However, database research has its own challenges as studies must be performed within the limitations of resources, which often are the product of complex healthcare systems. The primary ...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.2229

    authors： Hall GC,Sauer B,Bourke A,Brown JS,Reynolds MW,LoCasale R

    更新日期：2012-01-01 00:00:00

  • The risk of esophageal obstruction associated with an anti-allergy medication (Claritin-D 24-Hour--original formulation).

    abstract：PURPOSE:To investigate a possible increased risk of esophageal obstruction among users of loratadine and pseudoephedrine (Claritin-D 24-Hour [C-D 24], the original, round, extended-release formulation) compared to two other tablet formulations of loratadine. METHODS:Pharmacy data of 12 managed care plans were screened...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.816

    authors： Manda B,Drinkard CR,Shatin D,Graham DJ

    更新日期：2004-01-01 00:00:00

  • Effect of European Medicines Agency's restrictions on trimetazidine utilization in Portugal.

    abstract：PURPOSE:Following safety concerns regarding trimetazidine, the European Medicines Agency (EMA) recommended restrictions on its use. Our objective was to determine the impact of regulatory actions on trimetazidine utilization in Portugal. METHODS:Retrospective interrupted time-series analysis of monthly ambulatory phar...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.4585

    authors： Pinto D,Silva A,Heleno B,Rodrigues DS,Santos I,Caetano PA

    更新日期：2018-09-01 00:00:00

  • Use of non-vitamin K antagonist oral anticoagulants in Colombia: A descriptive study using a national administrative healthcare database.

    abstract：PURPOSE:We aimed to describe time-trends in the use of NOACs among a group of ambulatory patients with nonvalvular atrial fibrillation (NVAF) in Colombia and to describe treatment patterns and user characteristics. METHODS:Using the Audifarma S.A administrative healthcare database in Colombia, we identified 10 528 pat...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.5124

    authors： Machado-Alba JE,Gaviria-Mendoza A,Machado-Duque ME,Tovar-Yepes C,Ruigómez A,García Rodríguez LA

    更新日期：2020-10-15 00:00:00

  • Inter-practice variation in polypharmacy prevalence amongst older patients in primary care.

    abstract：PURPOSE:Complex medication management in older people with multiple chronic conditions can introduce practice variation in polypharmacy prevalence. This study aimed to determine the inter-practice variation in polypharmacy prevalence and examine how this variation was influenced by patient and practice characteristics....

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.4016

    authors： Sinnige J,Braspenning JC,Schellevis FG,Hek K,Stirbu I,Westert GP,Korevaar JC

    更新日期：2016-09-01 00:00:00

  • Development of an adverse events reporting form for Korean folk medicine.

    abstract：PURPOSE:We developed an adverse events (AEs) reporting form for Korean folk medicine. METHODS:The first version of the form was developed and tested in the clinical setting for spontaneous reporting of AEs. Additional revisions to the reporting form were made based on collected data and expert input. RESULTS:We devel...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.4077

    authors： Park JH,Choi SM,Moon S,Kim S,Kim B,Kim MK,Lee S

    更新日期：2017-05-01 00:00:00

  • Use of granulocyte colony-stimulating factor (G-CSF) and outcome in patients with non-chemotherapy agranulocytosis.

    abstract：PURPOSE:The use of granulocyte colony-stimulating factor (G-CSF) in the treatment of non-chemotherapy drug- induced agranulocytosis is controversial. We aimed at assessing the effect of G-CSF on the duration of agranulocytosis. METHODS:To assess the effect of G-CSF on the duration of agranulocytosis, a Cox proportiona...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1542

    authors： Ibáñez L,Sabaté M,Ballarín E,Puig R,Vidal X,Laporte JR,Agranulocytosis and Aplastic Anaemia Study Group of Barcelona.

    更新日期：2008-03-01 00:00:00

  • Assessment of colistimethate sodium (COLOBREATHE) risk minimization measures implemented in the European Union: A cross-sectional study.

    abstract：PURPOSE:To assess the effectiveness of additional risk minimization measures (aRMMs) implemented in Europe for colistimethate sodium (CMS) among healthcare professionals (HCPs) and patients/caregivers following safety concerns regarding incorrect use of CMS delivered via Turbospin inhaler. METHODS:A cross-sectional st...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.4940

    authors： Kaplan S,Patino O,Rainville C,Madison T

    更新日期：2020-02-01 00:00:00

  • Utilizing Medicare claims data for real‐time drug safety evaluations:is it feasible?

    abstract：PURPOSE:The Centers for Medicare & Medicaid Services claims comprise an administrative database of beneficiary-specific clinical information. This study evaluates the impacts of (i) claim information updates (claims adjudication) and (ii) delay in claim processing (claims delay) on real-time evaluation of health servic...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.2143

    authors： Hartzema AG,Racoosin JA,MaCurdy TE,Gibbs JM,Kelman JA

    更新日期：2011-07-01 00:00:00

  • Subtle issues in model specification and estimation of marginal structural models.

    abstract：:We review the concept of time-dependent confounding by using the example in paper "Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure" by Desai et al. and illustrate how to adjust for it by using inverse probability of treatment weighting t...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 评论,杂志文章

    doi：10.1002/pds.2306

    authors： Yang W,Joffe MM

    更新日期：2012-03-01 00:00:00